Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Pharmaceutical Biotechnology|January 31, 2013
Recombinant Salmonella vaccination technology and its application to human bacterial pathogensSong Zhang, Nancy Walters, Ling Cao, et al.Vaccine|January 24, 2007
Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonizationXinghong Yang, Nancy Walters, Amanda Robison, et al.Immunology and Cell Biology|June 2, 2020
Nasal vaccination of β7 integrin-deficient mice retains elevated IgA immunityTomasz Maślanka, Beata Clapp, Carol Hoffman, et al.Infection and Immunity|April 13, 2016
Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on TissueJodi F Hedges, Amanda Robison, Emily Kimmel, et al.Vaccines|July 2, 2021
Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following VaccinationJodi F Hedges, Macy A Thompson, Deann T Snyder, et al.Journal of Leukocyte Biology|January 15, 2014
Oral delivery of oligomeric procyanidins in Apple Poly® enhances type I IFN responses in vivoDeann T Snyder, Amanda Robison, Sharon Kemoli, et al.Infection and Immunity|January 21, 2016
Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 during Pulmonary Coxiella burnetii InfectionAndrew G Ramstead, Amanda Robison, Anne Blackwell, et al.Innate Immunity|April 21, 2023
A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infectionJodi F Hedges, Deann T Snyder, Amanda Robison, et al.Plos One|October 12, 2012
Flagella overexpression attenuates Salmonella pathogenesisXinghong Yang, Theresa Thornburg, Zhiyong Suo, et al.Frontiers in Immunology|June 27, 2022
An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse ModelJodi F Hedges, Deann T Snyder, Amanda Robison, et al.Pageof 2